Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001493152-19-008043

CFO and EVP gave up 171 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Wolff Allen · CFO and EVP

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-21 Shares withheld for taxes : show line 1 in the form −171 $2.89 $494 58,570 D
Loading xslF345X03/ownership.xml…